These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
681 related articles for article (PubMed ID: 25680271)
21. Helios Deficiency Predisposes the Differentiation of CD4 Skadow M; Penna VR; Galant-Swafford J; Shevach EM; Thornton AM J Immunol; 2019 Jul; 203(2):370-378. PubMed ID: 31167776 [TBL] [Abstract][Full Text] [Related]
22. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650 [TBL] [Abstract][Full Text] [Related]
23. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. Ray A; Basu S; Williams CB; Salzman NH; Dittel BN J Immunol; 2012 Apr; 188(7):3188-98. PubMed ID: 22368274 [TBL] [Abstract][Full Text] [Related]
24. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2. Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318 [TBL] [Abstract][Full Text] [Related]
25. Bcl10 is required for the development and suppressive function of Foxp3 Yang D; Zhao X; Lin X Cell Mol Immunol; 2021 Jan; 18(1):206-218. PubMed ID: 31595055 [TBL] [Abstract][Full Text] [Related]
26. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658 [TBL] [Abstract][Full Text] [Related]
27. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis. Sun JB; Czerkinsky C; Holmgren J J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081 [TBL] [Abstract][Full Text] [Related]
28. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Kawakami R; Kitagawa Y; Chen KY; Arai M; Ohara D; Nakamura Y; Yasuda K; Osaki M; Mikami N; Lareau CA; Watanabe H; Kondoh G; Hirota K; Ohkura N; Sakaguchi S Immunity; 2021 May; 54(5):947-961.e8. PubMed ID: 33930308 [TBL] [Abstract][Full Text] [Related]
29. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. Vang KB; Yang J; Pagán AJ; Li LX; Wang J; Green JM; Beg AA; Farrar MA J Immunol; 2010 Apr; 184(8):4074-7. PubMed ID: 20228198 [TBL] [Abstract][Full Text] [Related]
30. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Bailey-Bucktrout SL; Martinez-Llordella M; Zhou X; Anthony B; Rosenthal W; Luche H; Fehling HJ; Bluestone JA Immunity; 2013 Nov; 39(5):949-62. PubMed ID: 24238343 [TBL] [Abstract][Full Text] [Related]
31. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Mayer CT; Floess S; Baru AM; Lahl K; Huehn J; Sparwasser T Eur J Immunol; 2011 Mar; 41(3):716-25. PubMed ID: 21312192 [TBL] [Abstract][Full Text] [Related]
32. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes. Kornete M; Piccirillo CA Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694 [TBL] [Abstract][Full Text] [Related]
33. IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. Schuster M; Glauben R; Plaza-Sirvent C; Schreiber L; Annemann M; Floess S; Kühl AA; Clayton LK; Sparwasser T; Schulze-Osthoff K; Pfeffer K; Huehn J; Siegmund B; Schmitz I Immunity; 2012 Dec; 37(6):998-1008. PubMed ID: 23200824 [TBL] [Abstract][Full Text] [Related]
34. p27(Kip1) inhibits systemic autoimmunity through the control of Treg cell activity and differentiation. Iglesias M; Postigo J; Santiuste I; González J; Buelta L; Tamayo E; Merino J; Merino R Arthritis Rheum; 2013 Feb; 65(2):343-54. PubMed ID: 23124840 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Bar-On L; Birnberg T; Kim KW; Jung S Eur J Immunol; 2011 Feb; 41(2):291-8. PubMed ID: 21267999 [TBL] [Abstract][Full Text] [Related]
36. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs. Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067 [TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection. Cervantes-Barragán L; Firner S; Bechmann I; Waisman A; Lahl K; Sparwasser T; Thiel V; Ludewig B J Immunol; 2012 Apr; 188(8):3678-85. PubMed ID: 22407917 [TBL] [Abstract][Full Text] [Related]
38. RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory Cells. Andreas N; Potthast M; Geiselhöringer AL; Garg G; de Jong R; Riewaldt J; Russkamp D; Riemann M; Girard JP; Blank S; Kretschmer K; Schmidt-Weber C; Korn T; Weih F; Ohnmacht C J Immunol; 2019 Nov; 203(10):2602-2613. PubMed ID: 31578269 [TBL] [Abstract][Full Text] [Related]
39. The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells. Messina N; Fulford T; O'Reilly L; Loh WX; Motyer JM; Ellis D; McLean C; Naeem H; Lin A; Gugasyan R; Slattery RM; Grumont RJ; Gerondakis S J Autoimmun; 2016 Jun; 70():52-62. PubMed ID: 27068879 [TBL] [Abstract][Full Text] [Related]
40. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]